While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak competitive positioning.

Boot Barn, Five Below, The Ensign and GE HealthCare have been highlighted in this Screen of The Week article.

Tap four stocks with increasing P/E ratios to try out an out-of-the-box approach.

William Grogan will take over the chief finance job vacated by Jay Saccaro. Stifel analysts called Grogan’s “no-nonsense” mindset on setting expectations a strength.

Healthcare stocks were higher late Tuesday afternoon, with the NYSE Healthcare Index and the State S

Healthcare stocks were higher Tuesday afternoon, with the NYSE Healthcare Index rising 1.8% and the

While the Nasdaq 100 (^NDX) is filled with cutting-edge technology and consumer companies, not all are on solid footing. Some are dealing with declining demand, high costs, or regulatory pressures that could limit future upside.

Alpha Wealth Funds, LLC, an investment management company, released its Q2 2026 letter for the “Insiders Fund”. A copy of the letter is available to download here. The Fund lost 1.45% in June, while it was up 8.43% for the 2nd quarter and 0.75% YTD. This compares to the S&P 500’s -0.95%, 15.2%, and 9.98% […]

GE HealthCare Technologies stock has climbed 19.7% over the past month, yet its valuation checks still lean toward the shares looking cheap rather than stretched. The 19.7% gain over the past month points to a sharp reset in expectations that puts the current pricing under closer scrutiny for new buyers and existing holders. Recent expansion of ultrasound and breast imaging platforms can support expectations for future revenue, while execution risks around new product rollouts may affect how...

Earlier this month, GE HealthCare introduced the LOGIQ e Xi and LOGIQ e Si laptop ultrasound systems and launched the Invenia ABUS Prime and ABUS StreamVue breast imaging solutions, expanding its AI-enabled and cloud-connected ultrasound portfolio across multiple care settings. These product launches aim to standardize imaging workflows, support remote reading, and address dense-breast screening needs, potentially strengthening GE HealthCare’s position in high-value, technologically advanced...

GEHC vs. LMAT: Which Stock Is the Better Value Option?

GE HealthCare (GEHC) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Should investors be excited or worried when a stock crosses above the 200-day simple moving average?

Large-cap stocks usually command their industries because they have the scale to drive market trends. The flip side though is that their sheer size can limit growth as expanding further becomes an increasingly challenging task.

GE HealthCare has lagged the broader market despite strong earnings, while analysts remain moderately optimistic about its future prospects.

Mid-cap stocks often strike the right balance between having proven business models and market opportunities that can support $100 billion corporations. However, they face intense competition from scaled industry giants and can be disrupted by new innovative players vying for a slice of the pie.

Record backlog and orders surge, but Patient Care Solutions struggles weigh on margins.

GE HealthCare posted strong Q2 results with record backlog and book-to-bill, while reviewing a possible sale of its underperforming Patient Care Solutions segment.

Healthcare technology company GE HealthCare Technologies (NASDAQ:GEHC) reported Q2 CY2026 results beating Wall Street’s revenue expectations, with sales up 5.8% year on year to $5.30 billion. Its non-GAAP profit of $1.13 per share was 9.1% above analysts’ consensus estimates.

Record backlog and orders surge, but Patient Care Solutions struggles weigh on margins.

GE HealthCare Technologies (GEHC) is back in focus after its second quarter report highlighted 11% order growth, a record US$23.9b backlog, and maintained full year guidance, despite persistent pressure in Patient Care Solutions. See our latest analysis for GE HealthCare Technologies. The Q2 update and PCS review arrived alongside a sharp shift in sentiment, with GE HealthCare Technologies posting a 1-day share price return of 12.15% and a 7-day share price return of 17.08%. However, the year...

GE HealthCare Technologies stock has climbed 17.1% over the past week, yet the latest valuation work still points to a sizeable gap between the current share price and an intrinsic value estimate based on a Discounted Cash Flow (DCF) model. The 17.1% gain over the past week suggests sentiment has turned quickly, even though the longer term share performance has been far more muted. The recently announced long term Care Alliance with Catholic Health can support expectations for recurring...

In the past week, GE HealthCare Technologies Inc. reported second-quarter 2026 results showing revenue of US$5,295 million (up from US$5,007 million) and net income of US$561 million (up from US$486 million), alongside raised EPS guidance and the appointment of long-serving finance executive George Newcomb as interim CFO. The company also highlighted record organic order growth of 11.1% and a US$23.90 billion backlog powered by AI-enabled products, while its Patient Care Solutions unit faced...

Shares of healthcare technology company GE HealthCare Technologies (NASDAQ:GEHC) jumped 11% in the afternoon session after the company reported second-quarter 2026 results that surpassed Wall Street's expectations for both revenue and profit.

GE HealthCare Technologies Inc (GEHC) reports robust orders growth and a record backlog, while navigating inflationary pressures and operational challenges in its Patient Care Solutions segment.

Moby summary of GE HealthCare Technologies Inc.'s Q2 2026 earnings call

Stock Market Today: The Dow Jones index drops Wednesday ahead of the Fed decision and Fed Chair Warsh's comments. SK Hynix sells off.

Find insight on GE HealthCare Technologies, Bitcoin, Meituan more in the latest Market Talks covering Technology, Media and Telecom.

Cost increases have hit the company in 2026, but today's earnings report provides evidence of an oncoming improvement.

GE HealthCare beats second-quarter estimates as revenues rise 5.7%, orders climb 11.1% and backlog hits a record $23.9 billion.

GE HealthCare Technologies ran at the top of the S&P 500 Wednesday morning, while Humana was among major laggards after both companies posted better-than-expected Q2 earnings signaling a return to profit growth. GEHC broke above its recent trading range that followed its dive on Q1 results. Wednesday's stock action was pretty much the reversal of what we've seen this year for GEHC and HUM, with medical equipment stocks among the market's worst-performing industry groups and managed-care stocks ranked in the top tier.

GE HealthCare Technologies (NASDAQ:GEHC) reported second-quarter results marked by strong order growth, a record backlog and continued momentum in its Advanced Imaging Solutions and Pharmaceutical Diagnostics businesses, while Patient Care Solutions remained pressured by operational fulfillment issu

GE HealthCare reports earnings per share of $1.13 from sales of $5.3 billion. Wall Street was looking for $1.04 a share and $5.3 billion, respectively.

FEATURE Stock futures were lower Wednesday ahead of the Federal Reserve’s decision on interest rates. GE Healthcare Technologies led the ahead of the opening bell, rising 10%. The medical technology company reported higher sales and better-than-expected profit margins for the second quarter.

GE HealthCare Technologies Inc. (NASDAQ:GEHC) reported stronger-than-expected second-quarter results on Wednesday, with record order growth and revenue exceeding Wall Street forecasts, sending shares about 9% higher in pre-market trading.

The main US stock measures were mostly trending higher in Wednesday's premarket activity as traders

GE HealthCare (GEHC) delivered earnings and revenue surprises of +8.65% and +0.41%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

GE HealthCare reports earnings per share of $1.13 from sales of $5.3 billion. Wall Street was looking for $1.04 a share and $5.3 billion, respectively.

Investing.com -- GE HealthCare Technologies Inc. (NASDAQ:GEHC) reported second-quarter results before the open on Wednesday, exceeding Wall Street expectations.

GE HealthCare Technologies notched higher profit and revenue in the second quarter, boosted by increased orders across the business.

Healthcare technology company GE HealthCare Technologies (NASDAQ:GEHC) reported revenue ahead of Wall Street’s expectations in Q2 CY2026, with sales up 5.8% year on year to $5.30 billion. Its non-GAAP profit of $1.13 per share was 9.1% above analysts’ consensus estimates.

Get a deeper insight into the potential performance of GE HealthCare (GEHC) for the quarter ended June 2026 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.

Healthcare technology company GE HealthCare Technologies (NASDAQ:GEHC) will be reporting earnings this Wednesday before market open. Here’s what investors should know.

GE HealthCare Technologies Inc. (NASDAQ:GEHC) posted preliminary fiscal second-quarter 2026 financial results on July 23, reporting accelerated top-line growth and earnings that topped management’s prior expectations. The announcement was paired with news that Chief Financial Officer James (Jay) Saccaro will step down on August 14 to take an expanded role outside the medical technology industry. […]

GE HealthCare heads into Q2 earnings season with solid revenue drivers, but inflation and tariff costs may keep margins under pressure before an expected second-half recovery.

GE HealthCare's MIM Anyware offers secure browser-based imaging access to streamline workflows, collaboration and clinical decision-making.

GE Aerospace shares fell despite Q2 2026 earnings beats and raised full-year guidance, as investors weigh a rich 46x forward earnings valuation against a $210 billion backlog.

GE HealthCare's shares rise about 4% after unveiling a $500M, 10-year alliance to deploy 1,300 technologies across Catholic Health.

GE HealthCare Technologies and Catholic Health have entered a roughly $500m Care Alliance spanning 10 years. The agreement covers modernization of imaging, cardiology, and other specialty services across more than 40 Catholic Health sites. The partnership includes advanced imaging systems, AI-enabled tools, software, cloud solutions, and asset management services. GE HealthCare Technologies (NasdaqGS:GEHC), trading around $63.2, has seen its share price down 23.7% year to date and down...

GE HealthCare Technologies (GEHC) is back in focus after a new research collaboration with Mayo Clinic on the MI-BET theranostics trial for advanced prostate cancer, highlighting its molecular imaging and radioligand therapy capabilities. See our latest analysis for GE HealthCare Technologies. At a recent share price of US$63.20, GE HealthCare Technologies has seen the share price fall 13.66% over the past 90 days and the 1-year total shareholder return decline 16.09%, as investors reacted to...